We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
-3.69%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.23B
AUM Growth
+$247M
Cap. Flow
+$266M
Cap. Flow %
21.66%
Top 10 Hldgs %
61.87%
Holding
776
New
234
Increased
119
Reduced
104
Closed
282

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$172M
2
FCX icon
Freeport-McMoran
FCX
+$166M
3
TSLA icon
Tesla
TSLA
+$92.7M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$27.5M
5
PFE icon
Pfizer
PFE
+$25.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 24.5%
2 Healthcare 17.22%
3 Materials 15.97%
4 Technology 5.36%
5 Financials 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORLY icon
251
O'Reilly Automotive
ORLY
$75.3B
$507K 0.04%
11,100
-6,615
-37% -$295K
PGRE
252
DELISTED
Paramount Group
PGRE
$503K 0.04%
46,102
+31,966
+226% +$312K
MTUS icon
253
Metallus
MTUS
$900M
$503K 0.04%
22,975
-673
-3% -$11.8K
JBTM
254
JBT Marel
JBTM
$6.35B
$501K 0.04%
+4,229
New +$541K
ECHO
255
EchoStar
ECHO
$25.9B
$495K 0.04%
+20,353
New +$501K
ALV icon
256
Autoliv
ALV
$8.92B
$494K 0.04%
+6,464
New +$595K
BAH icon
257
Booz Allen Hamilton
BAH
$9.37B
$493K 0.04%
5,612
-10,562
-65% -$869K
PBF icon
258
PBF Energy
PBF
$7.86B
$492K 0.04%
20,196
-19,695
-49% -$372K
JOYY
259
JOYY Inc
JOYY
$3.77B
$490K 0.04%
13,337
+7,670
+135% +$346K
XOM icon
260
ExxonMobil
XOM
$662B
$489K 0.04%
5,925
-3,678
-38% -$286K
AOS icon
261
A.O. Smith
AOS
$8.48B
$488K 0.04%
+7,634
New +$556K
ZM icon
262
Zoom
ZM
$31.4B
$487K 0.04%
+4,152
New +$565K
CRK icon
263
Comstock Resources
CRK
$4.22B
$485K 0.04%
+37,200
New +$331K
WING icon
264
Wingstop
WING
$3.2B
$480K 0.04%
+4,090
New +$580K
RYTM icon
265
Rhythm Pharmaceuticals
RYTM
$7.95B
$474K 0.04%
41,108
-18,289
-31% -$161K
MHK icon
266
Mohawk Industries
MHK
$9.19B
$470K 0.04%
+3,781
New +$567K
BLKB icon
267
Blackbaud
BLKB
$2.09B
$468K 0.04%
+7,825
New +$510K
VNDA icon
268
Vanda Pharmaceuticals
VNDA
$304M
$467K 0.04%
+41,301
New +$543K
GGG icon
269
Graco
GGG
$13.5B
$460K 0.04%
6,592
+1,766
+37% +$127K
GWRE icon
270
Guidewire Software
GWRE
$14.4B
$460K 0.04%
+4,866
New +$465K
ALLY icon
271
Ally Financial
ALLY
$13.3B
$458K 0.04%
10,541
+2,361
+29% +$111K
LSTR icon
272
Landstar System
LSTR
$6.05B
$456K 0.04%
3,020
-7,541
-71% -$1.2M
WAT icon
273
Waters Corp
WAT
$40.4B
$451K 0.04%
1,454
-1,094
-43% -$356K
APPF icon
274
AppFolio
APPF
$7.07B
$445K 0.04%
3,927
+199
+5% +$22.9K
HCKT icon
275
Hackett Group
HCKT
$279M
$445K 0.04%
19,309
-14,391
-43% -$293K

Similar funds

Caxton Associates (New York)'s Q1 2022 Portfolio in Review

As of Q1 2022, Caxton Associates (New York) held 776 positions worth $1.23B, up 25% from $982M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Caxton Associates (New York) deployed $266M of net new capital in Q1 2022, opening 234 new positions and adding to 119 existing holdings. Its largest new stake was Aptiv: 1,293,400 shares worth $155M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 4.8% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Amazon, an estimated $7.44M trimmed.

  • Caxton Associates (New York)'s largest Q1 2022 buy was Aptiv: 1,293,400 shares worth $155M.
  • Caxton Associates (New York) added most to Tesla in Q1 2022, an estimated $92.7M increase.
  • Caxton Associates (New York)'s biggest Q1 2022 reduction was Amazon, cutting an estimated $7.44M.
  • Caxton Associates (New York) fully exited State Street SPDR S&P 500 ETF Trust in Q1 2022, selling an estimated $79M.
  • Caxton Associates (New York)'s ten largest holdings make up 62% of its $1.23B portfolio in Q1 2022.
  • Caxton Associates (New York) opened 234 new positions and closed 282 in Q1 2022.
  • Caxton Associates (New York)'s portfolio value rose 25% quarter-over-quarter to $1.23B.

Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.